You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma

  • Technology appraisal guidance
  • Reference number: TA169
  • Published:  25 March 2009
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Department of Health approval for the Technology Appraisal Committee to consider patient access schemes submitted for sorafenib and sunitinib

  • Department of Health approval of sunitinib patient access scheme

  • Department of Health approval of patient access scheme for sorafenib


This page was last updated: 30 March 2010

Back to top